Sonoscape Medical Corp. (300633) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

300633 Sonoscape Medical Corp.

Watchlist

28.15
-1.25-4.25%

Market Closed Jan 7 15:00 CST

12.18BMarket Cap50.18P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

SonoScape Medical's (SZSE:300633) Returns On Capital Not Reflecting Well On The Business
Simply Wall StDec 28, 2024 19:44 ET
CICC Starts SonoScape Medical at Outperform With 41.60 Yuan Price Target
MT NewswiresDec 23, 2024 04:05 ET · Ratings
Is SonoScape Medical (SZSE:300633) Using Too Much Debt?
Simply Wall StDec 13, 2024 19:26 ET
The Recent Pullback Must Have Dismayed SonoScape Medical Corp. (SZSE:300633) Insiders Who Own 55% of the Company
Simply Wall StNov 28, 2024 19:15 ET
Are SonoScape Medical Corp. (SZSE:300633) Investors Paying Above The Intrinsic Value?
Simply Wall StNov 13, 2024 17:33 ET
Earnings Miss: SonoScape Medical Corp. Missed EPS And Analysts Are Revising Their Forecasts
Simply Wall StOct 28, 2024 03:23 ET

Comments

Moomoo AI

Mar 25, 2024 01:05

SonoScape Medical Corp.'s high P/E ratio is worrisome considering its lower projected growth compared to the broader market. Investors retaining their stock at this high P/E ratio may face future disappointment if the P/E aligns with the growth outlook. Current prices are hard to justify unless conditions significantly improve.

Risks To Shareholder Returns Are Elevated At These Prices For SonoScape Medical Corp. (SZSE:300633)

Moomoo AI

Mar 11, 2024 21:07

Despite the recent downturn, long-term shareholders have seen a gain of 6% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering.

SonoScape Medical (SZSE:300633) Shareholders Have Earned a 19% CAGR Over the Last Three Years

Moomoo AI

Feb 26, 2024 01:10

SonoScape Medical's reinvestment for growth, despite lower short-term returns, has resulted in higher sales. The stock's modest 21% gain over five years suggests potential investment appeal if other fundamentals are sound.

Capital Allocation Trends At SonoScape Medical (SZSE:300633) Aren't Ideal

Moomoo AI

Jan 30, 2024 18:04

SonoScape Medical's consistent profit generation and significant insider ownership make it a strong contender for investor watchlists. The company's growth in profits and insider confidence are key highlights that add value for shareholders in the long term.

We Ran A Stock Scan For Earnings Growth And SonoScape Medical (SZSE:300633) Passed With Ease

Moomoo AI

Jan 16, 2024 21:31

SonoScape Medical's short term liquidity and more cash than debt suggest it can manage its debt safely. The company's 33% year-on-year EBIT growth is also a positive sign.

Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?

Heat List

Overall

No Data